• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大免疫规划(EPI)。1995年世界卫生组织非洲区域免疫接种时间表。

Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995.

出版信息

Wkly Epidemiol Rec. 1996 Mar 22;71(12):90-4.

PMID:8901335
Abstract

There are 48 countries/areas in this Region (Tables 1-3). No data are available from Reunion and Saint Helena. BCG is given at birth in 46 countries. Diphtheria-pertussis-tetanus (DPT) vaccine is used as a primary series of 3 doses in 46 countries. In 35 countries, DPT is given from 6 weeks of age; in 6 countries at 2 months of age (Angola, Botswana, Burkina Faso, Congo, Gambia and Zambia); and in 5 countries at 3 months of age (Algeria, Mauritius, Seychelles, Swaziland and Zimbabwe). Eight countries give 4 doses of DPT (Benin, Burundi, Congo, Equatorial Guinea, Rwanda, Seychelles, South Africa and Zambia) while 2 countries give 5 doses of DPT (Algeria and Togo). Diphtheria-tetanus (DT) is given in 3 countries: in Botswana at 6 years, in Mauritius at 2 and 5 years and in South Africa at 5 years of age. No Td* is given in any of the countries in this Region. Oral poliovirus vaccine (OPV) is used in a primary series of 3 doses simultaneously with DPT vaccine in all countries. Eighteen countries give OPV at birth. Measles vaccine is given at 9 months of age in 45 countries. Seychelles gives measles vaccine at 15 months of age. None of these countries give a combined measles-mumps-rubella (MMR) vaccine. Rubella vaccine alone is also not given in any of the countries in the Region. Hepatitis B vaccine is used in 7 countries (Botswana, Gabon, Gambia, Nigeria, South Africa, Uganda and Zimbabwe). It is given in 2 doses in 2 countries (Gambia and Nigeria) and at birth in 4 countries (Botswana, Gabon, Gambia and Nigeria). Thirty-one countries are at risk for yellow fever. However, yellow fever vaccine is given only in 10 countries (Central African Republic, Chad, Côte d'Ivoire, Gabon, Gambia, Ghana, Niger, Sao Tome and Principe, Senegal and Togo). Six countries give yellow fever vaccine at 9 months, Chad gives it at 6 months, Gabon and Sao Tome and Principe at 1 year of age and Togo at 10 months. Tetanus toxoid (TT) is used for pregnant women or non-pregnant women of childbearing age. The schedules include 2 to 5 doses. Forty-two countries use a 5-dose schedule. TT is given to schoolchildren in 5 countries (Botswana, Comoros, Guinea, Lesotho and Madagascar).

摘要

该区域有48个国家/地区(表1 - 3)。留尼汪岛和圣赫勒拿岛没有相关数据。46个国家在出生时接种卡介苗。46个国家将白喉 - 百日咳 - 破伤风(DPT)疫苗作为3剂的基础免疫程序。在35个国家,DPT疫苗从6周龄开始接种;在6个国家于2月龄接种(安哥拉、博茨瓦纳、布基纳法索、刚果、冈比亚和赞比亚);在5个国家于3月龄接种(阿尔及利亚、毛里求斯、塞舌尔、斯威士兰和津巴布韦)。8个国家接种4剂DPT(贝宁、布隆迪、刚果、赤道几内亚、卢旺达、塞舌尔、南非和赞比亚),而2个国家接种5剂DPT(阿尔及利亚和多哥)。3个国家接种白喉 - 破伤风(DT)疫苗:博茨瓦纳在6岁时接种,毛里求斯在2岁和5岁时接种,南非在5岁时接种。该区域任何国家都未接种破伤风类毒素疫苗(Td*)。所有国家口服脊髓灰质炎疫苗(OPV)均与DPT疫苗同时作为3剂的基础免疫程序接种。18个国家在出生时接种OPV。45个国家在9月龄接种麻疹疫苗。塞舌尔在15月龄接种麻疹疫苗。这些国家均未接种麻疹 - 腮腺炎 - 风疹联合疫苗(MMR)。该区域任何国家也未单独接种风疹疫苗。7个国家使用乙型肝炎疫苗(博茨瓦纳、加蓬、冈比亚、尼日利亚、南非、乌干达和津巴布韦)。2个国家接种2剂(冈比亚和尼日利亚),4个国家在出生时接种(博茨瓦纳、加蓬、冈比亚和尼日利亚)。31个国家有黄热病风险。然而,仅10个国家接种黄热病疫苗(中非共和国、乍得、科特迪瓦、加蓬、冈比亚、加纳、尼日尔、圣多美和普林西比、塞内加尔和多哥)。6个国家在9月龄接种黄热病疫苗,乍得在6月龄接种,加蓬和圣多美和普林西比在1岁时接种,多哥在10月龄接种。破伤风类毒素(TT)用于孕妇或育龄非孕妇。接种程序包括2至5剂。42个国家采用5剂接种程序。5个国家对学童接种TT(博茨瓦纳、科摩罗、几内亚、莱索托和马达加斯加)。

相似文献

1
Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995.扩大免疫规划(EPI)。1995年世界卫生组织非洲区域免疫接种时间表。
Wkly Epidemiol Rec. 1996 Mar 22;71(12):90-4.
2
Expanded programme on immunization (EPI) immunization schedules in the WHO Western Pacific Region, 1995.1995年世界卫生组织西太平洋区域扩大免疫规划(EPI)免疫接种时间表
Wkly Epidemiol Rec. 1996 May 3;71(18):133-7.
3
Expanded programme on immunization (EPI). Immunization schedules in the WHO eastern Mediterranean region, 1995.扩大免疫规划(EPI)。1995年世界卫生组织东地中海区域免疫接种时间表。
Wkly Epidemiol Rec. 1996 Jun 7;71(23):173-6.
4
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
5
Revisiting sub-Saharan African countries' drug problems: health, social, economic costs, and drug control policy.重新审视撒哈拉以南非洲国家的毒品问题:健康、社会、经济成本及毒品管制政策。
Subst Use Misuse. 2002 Feb;37(3):265-90. doi: 10.1081/ja-120002479.
6
EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.冈比亚8至9岁儿童中,由扩大免疫规划(EPI)疫苗诱导产生抗体的流行情况。
Trop Med Int Health. 2004 Oct;9(10):1044-9. doi: 10.1111/j.1365-3156.2004.01313.x.
7
A comparative review of governments' views on objectives and policy instruments in the field of population and development.各国政府对人口与发展领域目标及政策手段的观点比较综述。
Afr Popul Newsl. 1982 Jul-Dec(40-41):1-21.
8
Expanded programme on immunization (EPI). Immunization schedules in the WHO South-East Asia region, 1995.扩大免疫规划(EPI)。1995年世界卫生组织东南亚区域免疫规划时间表。
Wkly Epidemiol Rec. 1996 Mar 29;71(13):100-2.
9
Summary of country-level activities in population education in the African region: Unesco experience.非洲地区国家层面人口教育活动总结:联合国教科文组织的经验
Educafrica. 1985 Jun(12):199-207.
10
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.RTS,S/AS01E 候选疟疾疫苗与扩大免疫规划疫苗联合接种的安全性和有效性:一项随机、开放标签、2 期临床试验的 19 个月随访。
Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.

引用本文的文献

1
Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study.博茨瓦纳一家转诊医院中具有肝炎特征患者的乙型、丙型和丁型肝炎病毒感染血清流行率及危险因素:一项横断面研究
S Afr J Infect Dis. 2021 Jul 19;36(1):275. doi: 10.4102/sajid.v36i1.275. eCollection 2021.
2
Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique.肯尼亚、坦桑尼亚和莫桑比克综合疾病血清学监测揭示5至14岁儿童及≥15岁男性的破伤风免疫缺口
Am J Trop Med Hyg. 2017 Feb 8;96(2):415-420. doi: 10.4269/ajtmh.16-0452. Epub 2016 Dec 5.
3
Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.
综合证据以描述全国麻疹和风疹暴露及免疫史
Risk Anal. 2016 Jul;36(7):1427-58. doi: 10.1111/risa.12454. Epub 2015 Aug 6.
4
A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.对预防性治疗对当代撒哈拉以南非洲地区结核病公共卫生问题的潜在影响的重新审视。
Prev Med. 2004 Nov;39(5):1036-46. doi: 10.1016/j.ypmed.2004.04.008.